From: Increased migraine risk in osteoporosis patients: a nationwide population-based study
Variables | Osteoporosis | P value | |
---|---|---|---|
Yes (NÂ =Â 40,672) | No (NÂ =Â 40,672) | Â | |
Migraine patients, n (%) | 1110 (2.73) | 751 (1.85) | <0.001 |
Period of developing migraine, median (IQR), years | 3.5 (1.5–6.2) | 7.2 (4.8–10.5) | <0.001 |
Mean age at diagnosis of migraine, years | 57.9 (10.4) | 62.6 (10.3) | <0.001 |
Age group, n (%) | Â | Â | Â |
 20–49 | 7361 (18.10) | 7361 (18.10) |  |
 ≥50 | 33,311 (81.90) | 33,311 (81.90) | 1.000 |
Gender, n (%) | Â | Â | Â |
 Men | 7125 (17.52) | 7125 (17.52) |  |
 Women | 33,547 (82.48) | 33,547 (82.48) | 1.000 |
Charlson Comorbidity Index, n (%) | Â | Â | Â |
 0 | 1912 (4.70) | 7744 (19.04) |  |
 1–2 | 9667 (23.77) | 14,437 (35.50) |  |
 3–4 | 11,911 (29.29) | 9861 (24.25) |  |
 ≥5 | 17,182 (42.25) | 8630 (21.22) | <0.001 |
Co-morbidity, n (%) | Â | Â | Â |
 Hypertension | 28,521 (70.12) | 21,991 (54.07) | <0.001 |
 Diabetes mellitus | 15,693 (38.58) | 11,272 (27.71) | <0.001 |
 Hyperlipidemia | 24,923 (61.28) | 17,879 (43.96) | <0.001 |
 Depression | 8625 (21.21) | 4764 (11.71) | <0.001 |
 Asthma | 11,700 (28.77) | 7807 (19.20) | <0.001 |
 Allergic rhinitis | 18,146 (44.62) | 13,168 (32.38) | <0.001 |
 Psoriasis | 874 (2.15) | 583 (1.43) | <0.001 |
 Obesity | 1073 (2.64) | 857 (2.11) | <0.001 |
 Tobacco use disorder | 776 (1.91) | 422 (1.04) | <0.001 |
 Alcohol attributed disease | 1069 (2.63) | 780 (1.92) | <0.001 |